Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy

Magnetic Resonance Imaging

Volumn 28, Issue 6, 2010, Pages 812-819

  Doesch, Christina ^a   Huck, Sonia ^a   Böhm, Christoph K ^a   Michaely, Henrik ^a   Fluechter, Stephan ^a   Haghi, Dariusch ^a   Dinter, Dietmar ^a   Borggrefe, Martin ^a   Papavassiliu, Theano ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular magnetic resonance; Hypertrophic cardiomyopathy; Planimetry, semiquantitative score

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSTIC USE; EVALUATION STUDY; FEASIBILITY STUDY; IMAGE ENHANCEMENT; IMAGE PROCESSING; MIDDLE AGED; OBSERVER VARIATION; PROCEDURES; REPRODUCIBILITY;

CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 77953812310     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.03.034     Document Type: Article

References (26)

1. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001, 357:21-28.
2. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:2156-2164.
3. Moon J.C., De Arenaza D.P., Elkington A.G., Taneja A.K., John A.S., Wang D., et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2004, 44:554-560.
4. Papavassiliu T., Schnabel P., Schroder M., Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 2005, 26:2395.
5. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561-1567.
6. Comte A., Lalande A., Walker P.M., Cochet A., Legrand L., Cottin Y., et al. Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI. Eur Radiol 2004, 14:2182-2187.
7. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
8. Klein C., Nekolla S.G., Bengel F.M., Momose M., Sammer A., Haas F., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002, 105:162-167.
9. Amado L.C., Gerber B.L., Gupta S.N., Rettmann D.W., Szarf G., Schock R., et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004, 44:2383-2389.
10. Bondarenko O., Beek A.M., Twisk J.W., Visser C.A., van Rossum A.C. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. Eur Heart J 2008, 29:2000-2005.
11. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
12. Beek A.M., Kuhl H.P., Bondarenko O., Twisk J.W., Hofman M.B., van Dockum W.G., et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003, 42:895-901.
13. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., Lima J.A. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002, 106:1083-1089.
14. Heiberg E., Ugander M., Engblom H., Gotberg M., Olivecrona G.K., Erlinge D., et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 2008, 246:581-588.
15. Hsu L.Y., Natanzon A., Kellman P., Hirsch G.A., Aletras A.H., Arai A.E. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006, 23:298-308.
16. Ramani K., Judd R.M., Holly T.A., Parrish T.B., Rigolin V.H., Parker M.A., et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998, 98:2687-2694.
17. Nazarian S., Bluemke D.A., Lardo A.C., Zviman M.M., Watkins S.P., Dickfeld T.L., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005, 112:2821-2825.
18. Moon J.C., Reed E., Sheppard M.N., Elkington A.G., Ho S.Y., Burke M., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43:2260-2264.
19. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996, 93:841-842.
20. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002, 105:539-542.
21. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
22. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
23. Bondarenko O., Beek A.M., Hofman M.B., Kuhl H.P., Twisk J.W., van Dockum W.G., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005, 7:481-485.
24. Mahrholdt H., Wagner A., Holly T.A., Elliott M.D., Bonow R.O., Kim R.J., et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002, 106:2322-2327.
25. Kim R.J., Chen E.L., Lima J.A., Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996, 94:3318-3326.
26. Spiewak M., Malek L.A., Misko J., Chojnowska L., Milosz B., Klopotowski M., et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol 2009 Jun 10, [Epub ahead of print].